Early high intensity lipid-lowering therapy in STEMI patients with primary PCI improves myocardial perfusion

Back

ESC2025 Premium Access

Early high intensity lipid-lowering therapy in STEMI patients with primary PCI improves myocardial perfusion

Session: Pharmacotherapy in acute coronary syndromes (5)

Topic: Pharmacotherapy

Speaker: Professor A. Parkhomenko (Kyiv, UA)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Alexander Parkhomenko

Institute of Cardiology, Clinical and Regenerative Medicine, Kyiv (Ukraine)

1 presentation

0 follower

6 more presentations in this session

Prophylactic anticoagulation for left ventricular thrombus in patients with anterior myocardial infarction

Speaker: Doctor A. Gajulapalli (Stony Brook, US)

High-intensity lipid-lowering therapy accelerates early plaque regression: a FLOWPROMOTE sub study.

Speaker: Doctor N. Iraqi (Aarhus, DK)

De-escalation dual antiplatelet strategy in stabilized myocardial infarction patients with diabetes mellitus: post hoc analysis of the TALOS-AMI trial

Speaker: Doctor S. Kim (Seongnam, KR)

Efficacy of long-term beta-blocker therapy in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis

Speaker: Doctor P. Sajnani (Plymouth, GB)

Impact of beta-blocker carvedilol versus Bisoprolol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents

Speaker: Professor S. Park (Seoul, KR)

Access the full session

Pharmacotherapy in acute coronary syndromes (5)

Speakers: Professor A. Parkhomenko, Doctor A. Gajulapalli, Doctor N. Iraqi, Doctor S. Kim, Doctor P. Sajnani...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources